How we work
Editorial standards
How Truvex Research chooses, sources, writes and corrects its articles.
Sourcing
Every article cites at least two sources, linked in full. We prefer, in order: peer-reviewed papers (via PubMed or the journal), registered trials (ClinicalTrials.gov), regulators (FDA, DEA, FTC, state boards) and court records, then reputable news reporting. Press releases and vendor material are cited only as what a party said, never as evidence.
Attribution
Findings are reported as findings of a named study, with the model it used: cell culture, animal species or human participants, and how many. We say when a study is small, unreplicated, preclinical or funded by an interested party.
What we never write
- Dosing, administration routes, regimens, cycles or "protocols" for people.
- No claim that a compound treats, cures or prevents a disease.
- Product recommendations, prices or links to any store.
Combination research
When we cover compounds studied together ("stacks"), we report only what was actually tested in combination, and we state plainly when a combination has never been studied.
Risks
Every compound entry and safety article reports known adverse findings, regulatory warnings and contamination risks alongside the research, with sources.
Review and corrections
Articles are drafted with AI assistance and by our contributors. Every article is reviewed and approved by a human editor before it is published. When we find an error we correct it and note the date of the update on the article.